Published in Clin Infect Dis on June 15, 2009
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov (2009) 4.00
Artemisinin combination therapy for vivax malaria. Lancet Infect Dis (2010) 3.08
Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev (2013) 2.36
The anaemia of Plasmodium vivax malaria. Malar J (2012) 1.82
Geographical variation in Plasmodium vivax relapse. Malar J (2014) 1.73
Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J (2012) 1.72
Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J (2012) 1.61
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS One (2011) 1.54
Primaquine: the risks and the benefits. Malar J (2014) 1.51
Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One (2012) 1.29
Defying malaria: Fathoming severe Plasmodium vivax disease. Nat Med (2011) 1.18
Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax. Trends Parasitol (2012) 1.17
Global database of matched Plasmodium falciparum and P. vivax incidence and prevalence records from 1985-2013. Sci Data (2015) 1.16
Plasmodium vivax treatments: what are we looking for? Curr Opin Infect Dis (2011) 1.16
Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg (2014) 1.12
Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. PLoS Negl Trop Dis (2014) 1.10
A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific. PLoS One (2013) 1.07
Plasmodium vivax malaria endemicity in Indonesia in 2010. PLoS One (2012) 1.01
Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India. BMC Med (2015) 1.00
Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia. PLoS Negl Trop Dis (2013) 1.00
Severe anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study. PLoS Negl Trop Dis (2012) 1.00
Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission. J Infect Dis (2011) 0.98
Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med (2014) 0.98
Clinical and epidemiological profiles of severe malaria in children from Delhi, India. J Health Popul Nutr (2012) 0.98
Malaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life--the infectious bite preempts these hazards. Pathog Glob Health (2013) 0.94
Global Epidemiology of Plasmodium vivax. Am J Trop Med Hyg (2016) 0.93
Severe morbidity and mortality risk from malaria in the United States, 1985-2011. Open Forum Infect Dis (2014) 0.92
Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group. Malar J (2015) 0.92
Research challenges and gaps in malaria knowledge in Papua New Guinea. Acta Trop (2011) 0.92
Plasmodium malaria and antimalarial antibodies in the first year of life. Parasitology (2016) 0.89
Management of relapsing Plasmodium vivax malaria. Expert Rev Anti Infect Ther (2016) 0.88
Pernicious and threatening Plasmodium vivax as reality. Am J Trop Med Hyg (2014) 0.87
Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia. J Infect Dis (2014) 0.86
Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question. Infect Immun (2014) 0.86
Biochemical properties of a novel cysteine protease of Plasmodium vivax, vivapain-4. PLoS Negl Trop Dis (2010) 0.86
Malaria in children. Mediterr J Hematol Infect Dis (2012) 0.86
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand. CPT Pharmacometrics Syst Pharmacol (2014) 0.84
Severe congenital malaria acquired in utero. Am J Trop Med Hyg (2010) 0.82
Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum. PLoS One (2012) 0.82
Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria. Antimicrob Agents Chemother (2013) 0.82
A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes. Wellcome Open Res (2016) 0.82
Primaquine treatment and relapse in Plasmodium vivax malaria. Pathog Glob Health (2016) 0.81
Prevalence of Malaria Infection and Risk Factors Associated with Anaemia among Pregnant Women in Semiurban Community of Hazaribag, Jharkhand, India. Biomed Res Int (2015) 0.81
Genetic diversity and selection in three Plasmodium vivax merozoite surface protein 7 (Pvmsp-7) genes in a Colombian population. PLoS One (2012) 0.80
Plasma circulating nucleic acids levels increase according to the morbidity of Plasmodium vivax malaria. PLoS One (2011) 0.80
Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon. Mem Inst Oswaldo Cruz (2014) 0.80
Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand. J Infect Dis (2016) 0.79
Comparison of Clinical Profile between P. vivax and P. falciparum Malaria in Children: A Tertiary Care Centre Perspective from India. Malar Res Treat (2014) 0.79
Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life. PLoS One (2016) 0.77
A case of congenital plasmodium vivax malaria from a temperate region in Central China. Malar J (2012) 0.77
Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia. BMC Infect Dis (2016) 0.77
Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens. PLoS Med (2017) 0.77
Imperfect duplicate insertions type of mutations in plasmepsin V modulates binding properties of PEXEL motifs of export proteins in Indian Plasmodium vivax. PLoS One (2013) 0.76
Mutations of pvdhfr and pvdhps genes in vivax endemic-malaria areas in Kota Marudu and Kalabakan, Sabah. Malar J (2016) 0.75
The association between malaria and malnutrition among under-five children in Shashogo District, Southern Ethiopia: a case-control study. Infect Dis Poverty (2017) 0.75
Epidemiology of Plasmodium vivax in Indonesia. Am J Trop Med Hyg (2016) 0.75
Plasmodium vivax infection: a major determinant of severe anaemia in infancy. Malar J (2016) 0.75
[The problem of the use of Long-Lasting Insecticide Impregnated Mosquito Nets (LLIN) in children less than five years of age in Democratic Republic of Congo]. Pan Afr Med J (2016) 0.75
The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials. Int J Parasitol Drugs Drug Resist (2017) 0.75
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg (2000) 22.12
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Malaria in African infants and children in Southern Nigeria. Ann Trop Med Parasitol (1952) 7.55
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med (2008) 6.61
Severe anemia in Malawian children. N Engl J Med (2008) 5.20
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet (2007) 4.85
The pathophysiology of vivax malaria. Trends Parasitol (2009) 4.57
Epidemiology, malaria and pregnancy. Am J Trop Med Hyg (1984) 3.32
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis (2007) 3.27
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg (2006) 3.08
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis (2008) 3.01
The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg (2007) 2.72
Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J (2008) 2.41
Undernutrition as an underlying cause of malaria morbidity and mortality in children less than five years old. Am J Trop Med Hyg (2004) 2.29
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol (1995) 2.24
Defining childhood severe falciparum malaria for intervention studies. PLoS Med (2007) 2.22
The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg (1997) 2.12
Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Trop Med Int Health (1996) 1.87
Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium. Am J Trop Med Hyg (2001) 1.67
Congenital malaria in Thailand. Ann Trop Paediatr (2007) 1.67
Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun (2000) 1.64
Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol (2001) 1.53
A retrospective examination of anemia during infection of humans with Plasmodium vivax. Am J Trop Med Hyg (2003) 1.51
Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol (1987) 1.34
Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J Infect Dis (2008) 1.28
High incidence of asymptomatic malara infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. Am J Trop Med Hyg (1998) 1.24
Intermittent preventive antimalarial treatment in infants. Clin Infect Dis (2007) 1.23
Plasmodium vivax: a cause of malnutrition in young children. QJM (1997) 1.23
Malaria in the first 6 months of life in urban African infants with anemia. Am J Trop Med Hyg (2001) 1.19
Clinical characteristics of neonatal malaria. J Trop Pediatr (1995) 1.13
Malaria infection in infancy in rural Malawi. Am J Trop Med Hyg (1996) 1.12
Congenital malaria with atypical presentation: a case report from low transmission area in India. Malar J (2007) 1.08
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med (2008) 6.61
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One (2009) 5.81
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
The pathophysiology of vivax malaria. Trends Parasitol (2009) 4.57
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med (2007) 3.13
Artemisinin combination therapy for vivax malaria. Lancet Infect Dis (2010) 3.08
The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis (2008) 3.05
Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis (2007) 3.02
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis (2008) 3.01
Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A (2008) 2.80
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One (2007) 2.66
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J (2009) 2.64
Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J (2008) 2.41
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J (2007) 2.30
Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis (2011) 2.16
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol (2012) 1.95
Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis (2009) 1.86
The anaemia of Plasmodium vivax malaria. Malar J (2012) 1.82
Simplified antimalarial therapeutic monitoring: using the day-7 drug level? Trends Parasitol (2008) 1.70
Inferred relatedness and heritability in malaria parasites. Proc Biol Sci (2010) 1.69
Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J (2008) 1.69
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Clin Infect Dis (2011) 1.64
Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J (2012) 1.61
A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax (2010) 1.55
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS One (2011) 1.54
Plasmodium vivax trophozoites insensitive to chloroquine. Malar J (2008) 1.54
A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis (2010) 1.54
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51
Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. J Infect Dis (2006) 1.49
The global public health significance of Plasmodium vivax. Adv Parasitol (2012) 1.46
Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog (2009) 1.46
High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J Infect Dis (2009) 1.40
Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog (2010) 1.37
Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum. Malar J (2007) 1.35
Considerations on the use of nucleic acid-based amplification for malaria parasite detection. Malar J (2011) 1.32
Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J Infect Dis (2008) 1.28
Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J Infect Dis (2008) 1.26
Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia. PLoS Negl Trop Dis (2011) 1.23
L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One (2013) 1.20
Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria. Am J Trop Med Hyg (2007) 1.20
Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria. J Infect Dis (2012) 1.15
Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J Infect Dis (2005) 1.14
Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Malar J (2013) 1.14
Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. J Infect Dis (2010) 1.11
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development. Malar J (2012) 1.11
Improving case definitions for severe malaria. PLoS Med (2007) 1.09